The “Sheikha Latifa Bint Hamdan Unit for Cardiac Catheterisation Surgery” is being established at the Magdi Yacoub Global Heart Centre in Cairo by the directive of His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice President, Prime Minister, and Ruler of Dubai.
Sheikha Latifa Bint Hamdan initiative, inspired by the charitable works of the wife of Sheikh Mohammed, aims to deliver state-of-the-art medical treatment services, cutting-edge medical technologies, and the ability to conduct as many as 9,000 catheterisation procedures each year through the use of robotic surgical procedures.
The new facility will train 1,500 surgeons and doctors each year
The new facility will provide free cardiac treatment and catheterization surgeries to children and economically disadvantaged Arab patients, allowing them to receive necessary medical treatment without fear of financial burden.
This move will significantly contribute to the improvement of the Arab world’s healthcare sector, which has been hampered by a lack of medical facilities and financial constraints.
The “Sheikha Latifa Bint Hamdan Unit for Cardiac Catheterisation Surgery” at the Magdi Yacoub Global Heart Centre in Cairo, Egypt, will be outfitted with advanced 24-hour treatment services, including cutting-edge medical technology and robotic surgical capabilities.
This will allow the facility to perform up to 9,000 catheterisation procedures per year, providing patients with cutting-edge medical care.
Besides that, the Sheikha Latifa Bint Hamdan Unit for Cardiac Catheterisation Surgery will provide specialised medical training in the field of cardiac catheterisation surgery to doctors and surgeons. This will aid in the development of medical professionals’ skills in the Arab world, resulting in better patient outcomes.
The initiative is expected to make a significant contribution to the development of the Arab world’s healthcare sector and to provide a ray of hope to those who have struggled to access quality medical care.
The facility is expected to be completed in early 2024, with the primary goal of training doctors and surgeons in the field of cardiac catheterisation surgery. The initiative is expected to train up to 1,500 surgeons and doctors per year, helping to meet the Arab world’s growing demand for cardiac treatment.
According to the World Health Organization, cardiovascular disease is the leading cause of death in the Arab world (WHO).
The Sheikha Latifa Bint Hamdan Unit for Cardiac Catheterisation Surgery is an important step towards addressing this critical healthcare issue.
The facility will help to improve the standard of healthcare in the Arab world and save many lives by providing advanced medical technologies and specialised training to doctors and surgeons.
The World Health Organization reports that cardiovascular disease is the leading cause of death worldwide, accounting for 17.9 million deaths each year. According to WHO, cardiovascular diseases account for 54% of noncommunicable disease deaths in the Arab world.
The establishment of the “Sheikha Latifa Bint Hamdan Unit for Cardiac Catheterisation Surgery” is an important step towards addressing the region’s healthcare crisis.
The Magdi Yacoub Global Heart Centre in Cairo, Egypt, is the largest charity cardiovascular hospital in the Arab world and has now established the “Sheikha Latifa Bint Hamdan Unit for Cardiac Catheterisation Surgery”.
The Unit aims to close the regional gap in cardiac catheterisation treatment and provide access to a broader range of patients, particularly children. It is ideally situated to serve patients from all over the Arab world.
The Unit also aims to contribute to the development of healthcare capacity in the Arab world by training new cardiothoracic and cardiovascular specialists.
This will help to address the region’s medical professional shortage and improve healthcare outcomes for patients.
Professor Sir Magdi Yacoub, a well-known surgeon, thanked His Highness Sheikh Mohammed Bin Rashid Al Maktoum for his ongoing support of the Magdi Yacoub Global Heart Centre. He praised His Highness for his significant contributions to the Arab region’s development, particularly in the healthcare sector.
Shakhbout Medical City (SSMC) in Abu Dhabi successfully performed a leadless cardiac pacemaker procedure on an Emirati patient in 2022, using a newly-approved technology by the US FDA.
Due to the patient’s life-threateningly slow heart rate and multiple medical issues that could have increased the risk of complications with a conventional pacemaker, the cutting-edge technique was chosen.
SSMC, a collaboration between Abu Dhabi Health Services Company (SEHA) and the Mayo Clinic, is one of the UAE’s largest serious and complex care hospitals. D. Mario Njeim, a consultant cardiologist and cardiac electrophysiologist, explained the advantages of the leadless cardiac pacemaker in this case.
The newly implanted leadless pacemaker generates electrical pulses that correct the patient’s slow heart rhythm, known as bradycardia.
This pacemaker type offers improved battery life and the ability to map and analyze the optimal implantation location before fixation.
Another unique feature allows for pairing with a second leadless device, enabling communication between different heart chambers, and the device can be removed or replaced as needed.
The procedure to implant the FDA-approved device was minimally invasive, using a tube inserted through a groin blood vessel and attached to the heart, without a surgical incision.